Fig. 2From: Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease - A population-based studyMFD-free Survival (months) from CCALD Diagnosis for Patients with and without HSCT - Kaplan-Meier (N = 47)MFD gathers: loss of communication, use of wheelchair, incontinence, blindness, use of enteral feeding (nasogastric/gastrostomy) and loss of movement. HSCT only refers to allogenic transplantationsBack to article page